Recent news on Leflunomide

Research and Markets: Examine the M&A Activity of the Generics ...  -  May 18, 2007
Genetic Engineering News (press release),Court orders Apotex to halt sales of clopidogrel Recent product approvals Diltiazem hydrochloride Clopidogrel Zonisamide Ofloxacin otic Leflunomide tablets

French Guidelines for Pretreatment Screening Inadequate to ...  -  Apr 10, 2007
DG NewsAnalysis of their concomitant immunosuppressive therapies showed use of methotrexate in 19 patients, leflunomide in 2, azathiprine in 1 and salazopine in 5;

Predicting The Risk Of Rheumatoid Arthritis For Early Arthritis ...  -  Jan 30, 2007
Science Daily (press release)...(October 28, 2003) -- The disease modifying anti-rheumatic arthritis drug (DMARD), leflunomide does not have a higher risk of liver side effects than the

A 24-Year-Old Woman with Systemic Lupus Erythematosus, Seizures ...  -  Dec 20, 2006
New England Journal of Medicine (subscription),She had been treated continuously with corticosteroids, with the addition of methotrexate, azathioprine, mycophenolate, leflunomide, and etanercept at

Arthritis Clinical Trial Results Revealed  -  Jan 2, 2007
Journal of American Medical Association (subscription),...drugs that suppress the immune and/or inflammatory systems, including methotrexate, sulfasalazine, hydroxychloroquine, leflunomide, and cyclosporine.

A 24-Year-Old Woman with Systemic Lupus Erythematosus, Seizures ...  -  Dec 20, 2006
New England Journal of Medicine (subscription),She had been treated continuously with corticosteroids, with the addition of methotrexate, azathioprine, mycophenolate, leflunomide, and etanercept at

Cytotoxic and Glucocorticoid Agents Increase CV Risk in Rheumatoid ...  -  Nov 29, 2006
Medscape (subscription)Cytotoxic agents, such as azathioprine, cyclosporine, and leflunomide, increased the risk for cardiovascular events by a factor of 1.8, whether alone or

How To Create a New Consensus On Quality Improvement Measures in ...  -  Dec 12, 2006
Medscape (subscription)...a difficult 8 item HAQ (DHAQ), and a rescored 20 item HAQ (HAQ20): analyses in 2491 rheumatoid arthritis patients following leflunomide initiation.

The Impact Of Immunosuppressive Medications On Cardiovascular ...  -  Dec 1, 2006
Medical News Today (press release),This finding applied to azathioprine, cyclosporine, and leflunomide. Daniel Solomon, MD, MPH, the study's lead author and Associate Professor of Medicine at

Immunosuppressive medications and hospitalization for ...  -  Dec 1, 2006
HeartZine,Cytotoxic immunosuppressive agents other than MTX (azathioprine, cyclosporine, and leflunomide) were also associated with an increased risk of

For RA Cardioprotection, Biologics Found Equal to Methotrexate  -  Nov 29, 2006
MedPage Today,The cytotoxic immunosuppressive agents azathioprine, cyclosporine, and Arava (leflunomide) increased cardiovascular event risk the most of any group of

Options for treating ganciclovir-resistant CMV discussed at IDSA ...  Oct 16, 2006
There have been a few reports of using ‘immune boosting’ drugs (immunomodulators) to treat CMV, including sirolimus, roscovitine, and leflunomide. ... -Aidsmap, Some arthritis drugs may protect the heart  Aug 31, 2006
...a cohort of RA patients, the rate of acute heart attack was significantly lower in current users of any DMARD, including methotrexate, leflunomide (Arava), and ... -Scientific American

DOH:Further Action Taken To Tackle Obesity As Minister Announces ...  Aug 31, 2006
Leflunomide (Arava, Aventis Pharma Ltd) is a DMARD that is licensed for the treatment of adults with active psoriatic arthritis. ... -Medical News Today

Health Checkup: new treatments for rheumatoid arthritis  Sep 13, 2006
It has traditionally included the disease-modifying antirheumatic drugs hydroxychloroquine, sulfasalazine and methotrexate, and the more recent leflunomide. ... -Rochester Democrat and Chronicle

Alemtuzumab Induction Therapy  Sep 1, 2006
...patients. Leflunomide, intravenous immunoglobulin (IVIG), and reduction in immunosuppression were used to treat BKV infection. In ... -Medscape (subscription)

Clinical Trials in Kidney Transplantation  Sep 5, 2006
...improved transplant outcomes. FK778 is an analog of the active metabolite of leflunomide, but has a shorter half-life. FK778 reversibly ... -Medscape (subscription)

DMARD Use in Rheumatoid Arthritis Increases Risk for Tuberculosis  Aug 29, 2006
DMARD exposure was classified as biological (infliximab, etanercept or anakinra use), traditional (methotrexate, leflunomide, hydrohychloroquine, sulfasalazine ... -Medscape (subscription)

NICE Welcomes Referral Of New Work Programme Topics, UK  Aug 31, 2006
...varenicline for smoking cessation; alteplase for acute ischaemic stroke; drugs for refractory rheumatoid arthritis; adalimumab and leflunomide for the ... -Medical News Today

How To Create a New Consensus On Quality Improvement Measures in ...  -  12 Dec 2006
Medscape (subscription)...and RA-HAQ, a difficult 8 item HAQ (DHAQ), and a rescored 20 item HAQ (HAQ20): analyses in 2,491 rheumatoid arthritis patients following leflunomide initiation ...

Cytotoxic and Glucocorticoid Agents Increase CV Risk in Rheumatoid ...  -  Nov 29, 2006
Medscape (subscription)...monotherapy and with combination treatment, cytotoxic immunosuppressive agents other than methotrexate (azathioprine, cyclosporine, and leflunomide) were also ...

Impact of immunosuppressive medications on cardiovascular events ...  -  Nov 28, 2006
SpiritIndia,...when used without other drugs. This finding applied to azathioprine, cyclosporine, and leflunomide. Daniel Solomon, MD, MPH, the ...

Immunosuppressive medications and hospitalization for ...  -  Dec 1, 2006
HeartZine,Cytotoxic immunosuppressive agents other than MTX (azathioprine, cyclosporine, and leflunomide) were also associated with an increased risk of cardiovascular ...

For RA Cardioprotection, Biologics Found Equal to Methotrexate  -  Nov 29, 2006
MedPage Today,The cytotoxic immunosuppressive agents azathioprine, cyclosporine, and Arava (leflunomide) increased cardiovascular event risk the most of any group of agents ...

Refractory cytomegalovirus infection successfully treated after ...  Aug 15, 2006
2006 AUG 15 - (NewsRx.com) -- Foscarnet plus leflunomide successfully treats refractory cytomegalovirus infection following stem cell transplantation. ... -Therapeutics Daily (subscription)

Madrid's great discovery  Aug 14, 2006
You can save $3,168 a year by purchasing the generic drug Leflunomide instead of the brand arthritis medication Arava and an additional $1,728 a year when ... -Carlsbad Current Argus

Sanofi raises earnings forecasts on solid Q2  Aug 2, 2006
...of the antihistamine Allegra (fexofenadine), as well as the diabetes drug Amaryl (glimepiride), rheumatoid arthritis treatment Arava (leflunomide) and DDAVP ... -Pharma Times (subscription)

Antirheumatic drug use and the risk of acute myocardial infarction ...  Jul 29, 2006
This effect was consistent across all DMARDs, including methotrexate (RR 0.81, 95% CI 0.60-1.08), leflunomide (RR 0.28, 95% CI 0.12-0.65), and other ... -HeartZine

Mylan Calls for End to Abusive Practices That Delay Access to ...  Jul 20, 2006
In the case of the drug Arava(R), Aventis filed a citizen petition requesting that the FDA deny approval for generic leflunomide unless the generic could ... -PR Newswire

Current Use of Treatments for Rheumatoid Arthritis in Western ...  Jun 30, 2006
...includes: prednisolone, 10-15% of patients; methotrexate (MTX), 35-70%; (hydroxyl)chloroquinone (HCQ), 0-39%; sulfasalazine (SSZ), 2-33%; leflunomide, 2-18 ... -DG News

Sanofi-Aventis cheered as Acomplia cleared in Europe  Jun 22, 2006
...sales of some of its key players, including the antihistamine Allegra (fexofenadine), the diabetes drug Amaryl (glimepiride), Arava (leflunomide) for arthritis ... -Pharma Times (subscription)



DTB recommends caution with new psoriatic arthritis drugs  Jan 27, 2006
Leflunomide, etanercept, infliximab, and adalimumab are all licensed for the treatment of patients with arthritis in peripheral joints that is related to ... - Irish Medical News

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional